Kenvue urges US FDA to deny request for Tylenol's autism warning

Core Viewpoint - Kenvue has requested U.S. regulators to deny a petition that seeks to issue a warning regarding the potential autism risk associated with its over-the-counter pain medication Tylenol when used during pregnancy [1] Group 1 - Kenvue is advocating against the warning request, emphasizing the safety profile of Tylenol [1] - The petition for the warning suggests concerns about the medication's use during pregnancy and its potential link to autism [1]